ARTICLE | Company News
Isotechnika Inc., Atrium Medical deal
October 10, 2005 7:00 AM UTC
Atrium received an exclusive worldwide license to develop and commercialize ISA's TAFA93 and ISA247 compounds with drug-eluting devices for the non-systemic treatment of vascular, cardiovascular, ta...